ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,447,024 | +1.6% | 90,163 | +15.1% | 0.09% | -1.1% |
| Q2 2023 | $2,407,557 | -18.6% | 78,320 | +4.6% | 0.09% | -48.9% |
| Q4 2022 | $2,959,258 | -45.1% | 74,880 | -45.8% | 0.18% | -15.6% |
| Q1 2022 | $5,387,000 | +109.9% | 138,281 | +114.7% | 0.21% | +83.5% |
| Q4 2021 | $2,567,000 | +62.4% | 64,411 | +47.2% | 0.12% | +27.8% |
| Q3 2021 | $1,581,000 | -66.4% | 43,749 | -61.8% | 0.09% | -70.2% |
| Q2 2021 | $4,700,000 | +58.6% | 114,669 | +68.8% | 0.30% | +105.4% |
| Q1 2021 | $2,963,000 | – | 67,930 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |